• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼科溶液、眼表及一种独特的治疗性人工泪液配方。

Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation.

作者信息

Gilbard J P, Rossi S R, Heyda K G

机构信息

Cornea Research Unit, Eye Research Institute, Boston, Massachusetts 02114.

出版信息

Am J Ophthalmol. 1989 Apr 15;107(4):348-55. doi: 10.1016/0002-9394(89)90657-0.

DOI:10.1016/0002-9394(89)90657-0
PMID:2929705
Abstract

In rabbit studies, we found that extended exposure of the ocular surface to existing ophthalmic solutions resulted in gross surface abnormalities and decreases in conjunctival goblet cell density. We developed an electrolyte solution (solution 15) that preserves normal gross appearance, goblet cell density, corneal epithelial glycogen levels, and ocular surface morphologic characteristics after extended exposure to the rabbit ocular surface. We created an artificial tear formulation by adding a demulcent and a buffering system to solution 15 and reducing its osmolarity to 162 mOsm/l. We then compared our artificial tear formulation to Hypotears in a double-masked, crossover study involving 11 patients with dry-eye disorders. Our artificial tear formulation was more effective than Hypotears in decreasing tear film osmolarity and rose bengal staining, and was preferred subjectively by an eight-to-one margin.

摘要

在兔子研究中,我们发现眼表长期暴露于现有的眼科溶液会导致明显的表面异常以及结膜杯状细胞密度降低。我们研发了一种电解质溶液(溶液15),在兔子眼表长期暴露后,该溶液能保持正常的外观、杯状细胞密度、角膜上皮糖原水平以及眼表形态特征。我们通过向溶液15中添加一种润滑剂和一个缓冲系统,并将其渗透压降至162 mOsm/l,从而制成了一种人工泪液制剂。然后,我们在一项涉及11名干眼症患者的双盲交叉研究中,将我们的人工泪液制剂与Hypotears进行了比较。在降低泪膜渗透压和孟加拉玫瑰红染色方面,我们的人工泪液制剂比Hypotears更有效,并且在主观上以八比一的优势更受青睐。

相似文献

1
Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation.眼科溶液、眼表及一种独特的治疗性人工泪液配方。
Am J Ophthalmol. 1989 Apr 15;107(4):348-55. doi: 10.1016/0002-9394(89)90657-0.
2
An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca.一种基于电解质的溶液,可增加干燥性角结膜炎兔模型中的角膜糖原和结膜杯状细胞密度。
Ophthalmology. 1992 Apr;99(4):600-4. doi: 10.1016/s0161-6420(92)31929-3.
3
Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent.含羟丙基瓜尔胶作为胶凝剂的人工泪液溶液疗效的临床前研究。
Curr Eye Res. 2004 Jun;28(6):437-44. doi: 10.1080/02713680490503787.
4
Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.1% D-3-羟基丁酸滴眼液治疗干眼病安全性和有效性的随机、多中心、双盲研究
Sci Rep. 2016 Feb 11;6:20855. doi: 10.1038/srep20855.
5
Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.环孢素 A 眼药水联合人工泪液与单纯人工泪液治疗对功能性泪液缺乏综合征患者结膜杯状细胞密度的影响。
Eye Contact Lens. 2011 Sep;37(5):312-5. doi: 10.1097/ICL.0b013e31822563be.
6
Artificial tear composition and promotion of recovery of the damaged corneal epithelium.人工泪液组合物与促进受损角膜上皮的恢复
Cornea. 1993 Mar;12(2):115-20. doi: 10.1097/00003226-199303000-00004.
7
Natural history of disease in a rabbit model for keratoconjunctivitis sicca.兔干眼性角结膜炎模型中疾病的自然史。
Acta Ophthalmol Suppl (1985). 1989;192:95-101. doi: 10.1111/j.1755-3768.1989.tb07100.x.
8
Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.序贯人工泪液和环孢素乳剂疗法对结膜杯状细胞密度及转化生长因子-β2产生的影响。
Cornea. 2008 Jan;27(1):64-9. doi: 10.1097/ICO.0b013e318158f6dc.
9
Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye.使用Artelac Rebalance治疗轻中度干眼症可减轻不适症状并恢复眼表参数。
Eur J Ophthalmol. 2013 Jul-Aug;23(4):488-95. doi: 10.5301/ejo.5000267. Epub 2013 Mar 28.
10
Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.局部黏液溶解剂对泪液和眼表面的影响:一种黏液缺乏性干眼的合理动物模型。
Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3104-3114. doi: 10.1167/iovs.18-23860.

引用本文的文献

1
Physicochemical Properties of Hyaluronic Acid-Based Lubricant Eye Drops.基于透明质酸的润滑眼药水的物理化学性质
Transl Vis Sci Technol. 2019 Nov 1;8(6):2. doi: 10.1167/tvst.8.6.2. eCollection 2019 Nov.
2
Cationic Thiolated Poly(aspartamide) Polymer as a Potential Excipient for Artificial Tear Formulations.阳离子硫醇化聚天冬酰胺聚合物作为人工泪液制剂的潜在辅料
J Ophthalmol. 2016;2016:2647264. doi: 10.1155/2016/2647264. Epub 2016 May 23.
3
Human lacrimal gland regeneration: Perspectives and review of literature.人类泪腺再生:文献综述与展望
Saudi J Ophthalmol. 2014 Jan;28(1):12-8. doi: 10.1016/j.sjopt.2013.09.004.
4
Tear film osmolarity in patients with thyroid ophthalmopathy.甲状腺眼病患者的泪膜渗透压
Jpn J Ophthalmol. 2008 Jul-Aug;52(4):323-326. doi: 10.1007/s10384-008-0545-7. Epub 2008 Sep 5.
5
Effect of hyperosmolality on beta-defensin gene expression by human corneal epithelial cells.高渗对人角膜上皮细胞β-防御素基因表达的影响。
Cornea. 2006 Oct;25(9):1063-8. doi: 10.1097/01.ico.0000228785.84581.35.
6
[Long-term follow-up after autologous submandibular gland transplantation in scarring keratoconjunctivitis with absolute dry eyes].
Ophthalmologe. 2003 Dec;100(12):1079-84. doi: 10.1007/s00347-003-0861-8.
7
Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis.
Graefes Arch Clin Exp Ophthalmol. 2003 Mar;241(3):192-5. doi: 10.1007/s00417-002-0612-6. Epub 2003 Feb 15.
8
Diagnostic methods and treatment modalities of dry eye conditions.
Int Ophthalmol. 1993 Jun;17(3):113-25. doi: 10.1007/BF00942924.
9
Effects of artificial tears on corneal epithelial permeability in dry eyes.
Graefes Arch Clin Exp Ophthalmol. 1991;229(4):345-9. doi: 10.1007/BF00170693.